Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?
Voyager Therapeutics Ownership Summary
Voyager Therapeutics is owned by 60.74% institutional investors, 16.98% insiders, and 22.28% retail investors. Blackrock is the largest institutional shareholder, holding 9.30% of VYGR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in Voyager Therapeutics shares.
VYGR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Voyager Therapeutics | 60.74% | 16.98% | 22.28% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 5.31M | 9.30% | $42.02M |
Armistice capital | 5.20M | 9.10% | $41.13M |
Ecor1 capital | 3.92M | 6.86% | $30.99M |
Vanguard group | 3.04M | 5.32% | $24.04M |
Farallon capital management | 2.29M | 4.01% | $18.13M |
State street | 1.79M | 3.13% | $14.15M |
Great point partners | 1.60M | 2.80% | $12.67M |
Geode capital management | 1.07M | 1.88% | $8.49M |
American century companies | 1.02M | 1.78% | $8.06M |
Price t rowe associates inc /md/ | 989.55K | 1.73% | $7.83M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Great point partners | 1.60M | 2.43% | $12.67M |
Ecor1 capital | 3.92M | 0.95% | $30.99M |
Armistice capital | 5.20M | 0.52% | $41.13M |
Vestal point capital, lp | 600.00K | 0.35% | $4.75M |
Globeflex capital l p | 291.29K | 0.24% | $2.30M |
Farallon capital management | 2.29M | 0.09% | $18.13M |
Patriot financial group insurance agency | 112.20K | 0.09% | $636.16K |
Virtus investment advisers | 12.65K | 0.08% | $100.05K |
Clarivest asset management | 102.82K | 0.08% | $813.32K |
Ikarian capital | 55.86K | 0.08% | $441.83K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Great point partners | 1.60M | 2.43% | 1.60M |
Blackrock | 5.31M | 0.00% | 915.17K |
Armistice capital | 5.20M | 0.52% | 528.00K |
Bank of america corp /de/ | 648.76K | 0.00% | 294.32K |
American century companies | 1.02M | 0.00% | 249.66K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Acadian asset management | 106.83K | 0.00% | -353.02K |
Woodline partners lp | - | - | -300.00K |
Dimensional fund advisors lp | 813.68K | 0.00% | -291.88K |
Aqr capital management | 502.38K | 0.01% | -291.26K |
Vanguard group | 3.04M | 0.00% | -193.13K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Great point partners | 1.60M | 2.43% | 1.60M | $12.67M |
Omers administration | 162.40K | 0.01% | 162.40K | $1.28M |
Prudential financial | 115.30K | 0.00% | 115.30K | $912.02K |
Pdt partners | 75.70K | 0.06% | 75.70K | $598.83K |
Corebridge financial | 24.75K | 0.00% | 24.75K | $195.76K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -6.00 |
Russell investments group | -43.00 |
Country trust bank | -300.00 |
Pacer advisors | -508.00 |
Macroview investment management | -858.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 132 | 1.54% | 35,137,594 | -5.22% | 60 | 1.47% | 58 | -12.12% | 37 | -7.50% |
Jun 30, 2024 | 129 | -4.44% | 37,074,437 | 7.46% | 64 | 1.01% | 66 | -26.67% | 39 | 39.29% |
Mar 31, 2024 | 135 | 22.73% | 34,500,823 | 33.24% | 80 | 2.30% | 90 | 76.47% | 28 | -12.50% |
Dec 31, 2023 | 110 | -3.51% | 25,893,556 | -1.14% | 59 | 1.63% | 51 | -8.93% | 32 | -3.03% |
Sep 30, 2023 | 114 | 4.59% | 26,192,943 | 1.46% | 60 | 1.49% | 56 | -27.27% | 33 | 65.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.71M | 3.14% | - |
iShares Russell 2000 ETF | 1.22M | 2.23% | -4.67K |
Vanguard Institutional Extnd Mkt Idx Tr | 667.46K | 1.22% | 19.23K |
T. Rowe Price Health Sciences | 569.83K | 1.04% | -19.05K |
Fidelity Small Cap Index | 464.02K | 0.85% | -332.00 |
Vanguard Explorer Inv | 457.06K | 0.84% | - |
BlackRock Health Sciences Opps Inv A | 445.88K | 0.82% | - |
iShares Russell 2000 Value ETF | 421.45K | 0.77% | -11.80K |
BlackRock Health Sciences Term Trust | 363.32K | 0.67% | - |
iShares Biotechnology ETF | 292.16K | 0.53% | -2.11K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 14, 2025 | Swartz Robin | COO & CBO | Sell | $15.71K |
Jan 14, 2025 | Carter Todd Alfred | Chief Scientific Officer | Sell | $6.11K |
Dec 23, 2024 | Swartz Robin | COO&CBO | Sell | $36.73K |
Oct 02, 2024 | Fahey Sandell Jacquelyn | Chief Legal Officer | Sell | $34.91K |
Apr 02, 2024 | Swartz Robin | Chief Operating Officer | Sell | $13.41K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 2 |
2024 Q3 | - | - |
2024 Q2 | - | 2 |
2024 Q1 | - | 7 |
2023 Q4 | - | 1 |
VYGR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools